Financial Results for Quarter and Half Year ended 30th September 2025.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 4.3 pts more than Nifty Microcap 250 and 5.2 pts more than its Trading - Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Yash Chemex Limited reported a sharp jump in revenue but weaker profitability for Q2 and H1 FY26. On a standalone basis, revenue from operations rose 45% YoY to Rs. 2,256 lakhs in Q2 and 72% to Rs. 4,031 lakhs in H1, while standalone net profit was nearly flat at Rs. 75.85 lakhs in H1 (vs Rs. 75.53 lakhs). On a consolidated basis (including subsidiary Yasons Chemex Care Limited), revenue grew 58% YoY in Q2 to Rs. 3,865 lakhs and 81% in H1 to Rs. 6,875 lakhs, but consolidated net profit fell 24% in H1 to Rs. 177 lakhs from Rs. 234 lakhs. Operating margins compressed notably on a standalone basis (H1 PBT margin ~2.5% vs ~5.1% prior year). Statutory auditor S. L. Patel & Co. issued an unmodified (clean) limited review opinion on both sets of results.
Strong top-line growth is a positive, but the sharp margin compression and decline in consolidated profits despite higher revenue may weigh on the stock. Investors should watch whether cost controls and the new subsidiary contribution improve profitability in coming quarters.